Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Sunshine Lake Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	23,811	26,274	8,412	8,351	5,720	5,368
Market Cap Growth	200.65%	212.32%	0.74%	46.00%	6.56%	-30.92%
Enterprise Value	27,339	34,991	9,289	9,299	9,130	7,738
Last Close Price	41.34	45.60	32.84	32.60	22.33	20.95
PE Ratio	67.54	86.66	16.38	3.80	66.05	-
PS Ratio	4.44	4.90	2.12	1.20	1.35	4.79
PB Ratio	4.93	5.44	0.93	0.96	0.83	0.73
P/TBV Ratio	6.02	6.65	1.32	1.41	1.71	1.19
P/FCF Ratio	-	-	-	5.70	4.48	-
P/OCF Ratio	-	-	88.41	4.53	2.98	-
EV/Sales Ratio	5.10	6.53	2.34	1.34	2.16	6.90
EV/EBITDA Ratio	22.86	29.26	8.29	2.66	11.68	-
EV/EBIT Ratio	35.54	45.49	13.05	3.03	25.02	-
EV/FCF Ratio	-	-	-	6.35	7.15	-
Debt / Equity Ratio	1.08	1.08	0.26	0.33	0.63	0.53
Debt / EBITDA Ratio	4.35	4.35	2.10	0.82	5.46	-
Debt / FCF Ratio	-	-	-	1.96	3.38	-
Net Debt / Equity Ratio	0.73	0.73	0.10	0.12	0.43	0.34
Net Debt / EBITDA Ratio	2.96	2.96	0.79	0.30	3.77	-9.98
Net Debt / FCF Ratio	-	-	-0.94	0.70	2.31	-2.02
Asset Turnover	0.39	0.39	0.30	0.51	0.33	0.09
Inventory Turnover	1.58	1.58	1.76	3.62	3.02	1.31
Quick Ratio	0.56	0.56	1.29	0.87	0.46	1.36
Current Ratio	0.77	0.77	1.77	1.40	1.01	1.66
Return on Equity (ROE)	4.20%	4.20%	5.87%	26.50%	0.81%	-10.57%
Return on Assets (ROA)	3.54%	3.54%	3.32%	14.16%	1.80%	-2.85%
Return on Invested Capital (ROIC)	5.65%	5.04%	6.14%	27.75%	3.85%	-6.47%
Return on Capital Employed (ROCE)	11.60%	11.60%	7.00%	33.20%	4.60%	-4.90%
Earnings Yield	1.27%	1.15%	6.11%	26.29%	1.51%	-13.44%
FCF Yield	-	-	-11.12%	17.54%	22.33%	-23.30%
Buyback Yield / Dilution	-114.82%	-114.82%	-	-	-	20.42%
Total Shareholder Return	-101.05%	-114.82%	-	-	-	20.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.